Stem cells and Alzheimer's disease essay
Despite advances in stem cell technology, borne out by encouraging preclinical use of stem cells in animal models of Alzheimer's disease, the number of clinical trials evaluating the efficacy of stem cell therapy is limited, with the results of many ongoing clinical trials of cell therapy for the Alzheimer's disease. still pending. Mesenchymal stem cells from MSCs have been purposely selected for publication in the range of years, i.e. most years, to evaluate the effectiveness of stem cell therapy in Alzheimer's disease using current data. Flowchart of the literature search according to guidelines. Recent developments in stem cell technology are opening new doors for patients suffering from diseases and conditions that have yet to be treated. Stem cell-based therapy, including human pluripotency. 1. About Alzheimer's disease. The current review focuses on Alzheimer's disease AD, the long-term, neurodegenerative disease that affects the largest number of patients in the world 1,2,3. For these patients, the lack of fully effective therapies was and is a serious problem. Use one of the following formats to cite this article in your essay, paper, or report: APA. Patel, HH. 2019, Stem cell therapy for Alzheimer's disease. The future hope of generated induced pluripotent stem cells iPS cells, from Alzheimer's disease patients, is manifold. First, they could help uncover new mechanisms of the disease, which could lead to the development of new and unprecedented drugs for patients. Second, they can also be used directly for STEM CELLS welcomes original articles and brief reviews describing basic laboratory research. stem cells and the. factor I IGF-I, HK532-IGF-I, is characterized in this report. The cell line is currently being investigated as a cellular therapy for Alzheimer's disease. HK532-IGF-I cells differentiated preferentially. Alzheimer's disease AD is a chronic, progressive, and fatal neurodegenerative disorder characterized by memory failure, cognitive impairment, as well as behavioral and psychological manifestations. Drugs can only moderately control, but not alleviate, clinical symptoms. Results based on animal models are,